Aurinia Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.About AUPH
Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
CEOPeter S. Greenleaf
CEOPeter S. Greenleaf
Employees130
Employees130
HeadquartersEdmonton, Alberta
HeadquartersEdmonton, Alberta
Founded1993
Founded1993
Employees130
Employees130
AUPH Key Statistics
Market cap2.02B
Market cap2.02B
Price-Earnings ratio26.57
Price-Earnings ratio26.57
Dividend yield—
Dividend yield—
Average volume1.68M
Average volume1.68M
High today$15.50
High today$15.50
Low today$14.76
Low today$14.76
Open price$14.77
Open price$14.77
Volume1.07M
Volume1.07M
52 Week high$16.48
52 Week high$16.48
52 Week low$6.55
52 Week low$6.55
Stock Snapshot
With a market cap of 2.02B, Aurinia Pharmaceuticals(AUPH) trades at $15.50. The stock has a price-to-earnings ratio of 26.57.
On 2025-12-04, Aurinia Pharmaceuticals(AUPH) stock traded between a low of $14.76 and a high of $15.50. Shares are currently priced at $15.50, which is +5.0% above the low and 0.0% below the high.
The Aurinia Pharmaceuticals(AUPH)'s current trading volume is 1.07M, compared to an average daily volume of 1.68M.
In the last year, Aurinia Pharmaceuticals(AUPH) shares hit a 52-week high of $16.48 and a 52-week low of $6.55.
In the last year, Aurinia Pharmaceuticals(AUPH) shares hit a 52-week high of $16.48 and a 52-week low of $6.55.
Analyst ratings
57%
of 7 ratingsBuy
57.1%
Hold
42.9%
Sell
0%
People also own
Based on the portfolios of people who own AUPH. This list is generated using Robinhood data, and it’s not a recommendation.